Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies

Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2014-05, Vol.5
Hauptverfasser: Haselmayer, Philipp, Camps, Montserrat, Muzerelle, Mathilde, El Bawab, Samer, Waltzinger, Caroline, Bruns, Lisa, Abla, Nada, Polokoff, Mark A., Jond-Necand, Carole, Gaudet, Marilène, Benoit, Audrey, Bertschy Meier, Dominique, Martin, Catherine, Gretener, Denise, Lombardi, Maria Stella, Grenningloh, Roland, Ladel, Christoph, Petersen, Jørgen Søberg, Gaillard, Pascale, Ji, Hong
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Frontiers in immunology
container_volume 5
creator Haselmayer, Philipp
Camps, Montserrat
Muzerelle, Mathilde
El Bawab, Samer
Waltzinger, Caroline
Bruns, Lisa
Abla, Nada
Polokoff, Mark A.
Jond-Necand, Carole
Gaudet, Marilène
Benoit, Audrey
Bertschy Meier, Dominique
Martin, Catherine
Gretener, Denise
Lombardi, Maria Stella
Grenningloh, Roland
Ladel, Christoph
Petersen, Jørgen Søberg
Gaillard, Pascale
Ji, Hong
description
doi_str_mv 10.3389/fimmu.2014.00233
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3389_fimmu_2014_00233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3389_fimmu_2014_00233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1963-22c6699238d594751f085a9a25c7d28848835b3d8750e81913117930c24fc6703</originalsourceid><addsrcrecordid>eNpN0DFOwzAUBmALgURVujP6Aim2n5PYI4oKVESlUsscuY6tGKVJZDtIwB04DSeAi0ELA2_53_L_w4fQJSVzACGvrNvvxzkjlM8JYQAnaEKzjCfAGD_995-jWQhP5Oe4BIB0gt6KRnmlo_HuVUXXd7i3eNU_mxavl3D_9f75gZdd43Yu9j5gFfC6j6aLTrV42xivBjNGpwO2vcebcoFVV-NyHMaAV2ZovIsuYNfhtTdJ0brO6Z_iJo61M-ECnVnVBjP7yyl6vFlsi7ukfLhdFtdloqnMIGFMZ5mUDESdSp6n1BKRKqlYqvOaCcGFgHQHtchTYgSVFCjNJRDNuNVZTmCKyO-u9n0I3thq8G6v_EtFSXXwq45-1cGvOvrBN6xwZL4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies</title><source>PMC (PubMed Central)</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central Open Access</source><creator>Haselmayer, Philipp ; Camps, Montserrat ; Muzerelle, Mathilde ; El Bawab, Samer ; Waltzinger, Caroline ; Bruns, Lisa ; Abla, Nada ; Polokoff, Mark A. ; Jond-Necand, Carole ; Gaudet, Marilène ; Benoit, Audrey ; Bertschy Meier, Dominique ; Martin, Catherine ; Gretener, Denise ; Lombardi, Maria Stella ; Grenningloh, Roland ; Ladel, Christoph ; Petersen, Jørgen Søberg ; Gaillard, Pascale ; Ji, Hong</creator><creatorcontrib>Haselmayer, Philipp ; Camps, Montserrat ; Muzerelle, Mathilde ; El Bawab, Samer ; Waltzinger, Caroline ; Bruns, Lisa ; Abla, Nada ; Polokoff, Mark A. ; Jond-Necand, Carole ; Gaudet, Marilène ; Benoit, Audrey ; Bertschy Meier, Dominique ; Martin, Catherine ; Gretener, Denise ; Lombardi, Maria Stella ; Grenningloh, Roland ; Ladel, Christoph ; Petersen, Jørgen Søberg ; Gaillard, Pascale ; Ji, Hong</creatorcontrib><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2014.00233</identifier><language>eng</language><ispartof>Frontiers in immunology, 2014-05, Vol.5</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1963-22c6699238d594751f085a9a25c7d28848835b3d8750e81913117930c24fc6703</citedby><cites>FETCH-LOGICAL-c1963-22c6699238d594751f085a9a25c7d28848835b3d8750e81913117930c24fc6703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Haselmayer, Philipp</creatorcontrib><creatorcontrib>Camps, Montserrat</creatorcontrib><creatorcontrib>Muzerelle, Mathilde</creatorcontrib><creatorcontrib>El Bawab, Samer</creatorcontrib><creatorcontrib>Waltzinger, Caroline</creatorcontrib><creatorcontrib>Bruns, Lisa</creatorcontrib><creatorcontrib>Abla, Nada</creatorcontrib><creatorcontrib>Polokoff, Mark A.</creatorcontrib><creatorcontrib>Jond-Necand, Carole</creatorcontrib><creatorcontrib>Gaudet, Marilène</creatorcontrib><creatorcontrib>Benoit, Audrey</creatorcontrib><creatorcontrib>Bertschy Meier, Dominique</creatorcontrib><creatorcontrib>Martin, Catherine</creatorcontrib><creatorcontrib>Gretener, Denise</creatorcontrib><creatorcontrib>Lombardi, Maria Stella</creatorcontrib><creatorcontrib>Grenningloh, Roland</creatorcontrib><creatorcontrib>Ladel, Christoph</creatorcontrib><creatorcontrib>Petersen, Jørgen Søberg</creatorcontrib><creatorcontrib>Gaillard, Pascale</creatorcontrib><creatorcontrib>Ji, Hong</creatorcontrib><title>Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies</title><title>Frontiers in immunology</title><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpN0DFOwzAUBmALgURVujP6Aim2n5PYI4oKVESlUsscuY6tGKVJZDtIwB04DSeAi0ELA2_53_L_w4fQJSVzACGvrNvvxzkjlM8JYQAnaEKzjCfAGD_995-jWQhP5Oe4BIB0gt6KRnmlo_HuVUXXd7i3eNU_mxavl3D_9f75gZdd43Yu9j5gFfC6j6aLTrV42xivBjNGpwO2vcebcoFVV-NyHMaAV2ZovIsuYNfhtTdJ0brO6Z_iJo61M-ECnVnVBjP7yyl6vFlsi7ukfLhdFtdloqnMIGFMZ5mUDESdSp6n1BKRKqlYqvOaCcGFgHQHtchTYgSVFCjNJRDNuNVZTmCKyO-u9n0I3thq8G6v_EtFSXXwq45-1cGvOvrBN6xwZL4</recordid><startdate>20140522</startdate><enddate>20140522</enddate><creator>Haselmayer, Philipp</creator><creator>Camps, Montserrat</creator><creator>Muzerelle, Mathilde</creator><creator>El Bawab, Samer</creator><creator>Waltzinger, Caroline</creator><creator>Bruns, Lisa</creator><creator>Abla, Nada</creator><creator>Polokoff, Mark A.</creator><creator>Jond-Necand, Carole</creator><creator>Gaudet, Marilène</creator><creator>Benoit, Audrey</creator><creator>Bertschy Meier, Dominique</creator><creator>Martin, Catherine</creator><creator>Gretener, Denise</creator><creator>Lombardi, Maria Stella</creator><creator>Grenningloh, Roland</creator><creator>Ladel, Christoph</creator><creator>Petersen, Jørgen Søberg</creator><creator>Gaillard, Pascale</creator><creator>Ji, Hong</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140522</creationdate><title>Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies</title><author>Haselmayer, Philipp ; Camps, Montserrat ; Muzerelle, Mathilde ; El Bawab, Samer ; Waltzinger, Caroline ; Bruns, Lisa ; Abla, Nada ; Polokoff, Mark A. ; Jond-Necand, Carole ; Gaudet, Marilène ; Benoit, Audrey ; Bertschy Meier, Dominique ; Martin, Catherine ; Gretener, Denise ; Lombardi, Maria Stella ; Grenningloh, Roland ; Ladel, Christoph ; Petersen, Jørgen Søberg ; Gaillard, Pascale ; Ji, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1963-22c6699238d594751f085a9a25c7d28848835b3d8750e81913117930c24fc6703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haselmayer, Philipp</creatorcontrib><creatorcontrib>Camps, Montserrat</creatorcontrib><creatorcontrib>Muzerelle, Mathilde</creatorcontrib><creatorcontrib>El Bawab, Samer</creatorcontrib><creatorcontrib>Waltzinger, Caroline</creatorcontrib><creatorcontrib>Bruns, Lisa</creatorcontrib><creatorcontrib>Abla, Nada</creatorcontrib><creatorcontrib>Polokoff, Mark A.</creatorcontrib><creatorcontrib>Jond-Necand, Carole</creatorcontrib><creatorcontrib>Gaudet, Marilène</creatorcontrib><creatorcontrib>Benoit, Audrey</creatorcontrib><creatorcontrib>Bertschy Meier, Dominique</creatorcontrib><creatorcontrib>Martin, Catherine</creatorcontrib><creatorcontrib>Gretener, Denise</creatorcontrib><creatorcontrib>Lombardi, Maria Stella</creatorcontrib><creatorcontrib>Grenningloh, Roland</creatorcontrib><creatorcontrib>Ladel, Christoph</creatorcontrib><creatorcontrib>Petersen, Jørgen Søberg</creatorcontrib><creatorcontrib>Gaillard, Pascale</creatorcontrib><creatorcontrib>Ji, Hong</creatorcontrib><collection>CrossRef</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haselmayer, Philipp</au><au>Camps, Montserrat</au><au>Muzerelle, Mathilde</au><au>El Bawab, Samer</au><au>Waltzinger, Caroline</au><au>Bruns, Lisa</au><au>Abla, Nada</au><au>Polokoff, Mark A.</au><au>Jond-Necand, Carole</au><au>Gaudet, Marilène</au><au>Benoit, Audrey</au><au>Bertschy Meier, Dominique</au><au>Martin, Catherine</au><au>Gretener, Denise</au><au>Lombardi, Maria Stella</au><au>Grenningloh, Roland</au><au>Ladel, Christoph</au><au>Petersen, Jørgen Søberg</au><au>Gaillard, Pascale</au><au>Ji, Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies</atitle><jtitle>Frontiers in immunology</jtitle><date>2014-05-22</date><risdate>2014</risdate><volume>5</volume><issn>1664-3224</issn><eissn>1664-3224</eissn><doi>10.3389/fimmu.2014.00233</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2014-05, Vol.5
issn 1664-3224
1664-3224
language eng
recordid cdi_crossref_primary_10_3389_fimmu_2014_00233
source PMC (PubMed Central); DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central Open Access
title Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A04%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Novel%20PI3K%C3%8E%C2%B4%20Inhibitors%20as%20Potential%20Therapeutics%20for%20SLE%20and%20Lupus%20Nephritis%20in%20Pre-Clinical%20Studies&rft.jtitle=Frontiers%20in%20immunology&rft.au=Haselmayer,%20Philipp&rft.date=2014-05-22&rft.volume=5&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2014.00233&rft_dat=%3Ccrossref%3E10_3389_fimmu_2014_00233%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true